S100A7 and Alzheimer disease: Psoriasin (S100A7) is an important effector molecule of the cutaneous barrier and is abundantly expressed in psoriatic and AD keratinocytes with epidermal barrier disruption significantly enhancing psoriasin expression [75, 76].